- Home
- SYRE vs BTE Comparison
SYRE vs BTE Comparison
Compare SYRE & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | BTE |
|---|---|---|
| Founded | 2013 | 1993 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | BTE |
|---|---|---|
| Price | $34.16 | $3.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $56.50 | N/A |
| AVG Volume (30 Days) | 569.5K | ★ 18.9M |
| Earning Date | 02-26-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $2,194,819,404.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.26 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.91 | $1.36 |
| 52 Week High | $35.31 | $3.63 |
Technical Indicators
Market Signals| Indicator | SYRE | BTE |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 55.39 |
| Support Level | $30.92 | $3.36 |
| Resistance Level | $34.07 | $3.57 |
| Average True Range (ATR) | 1.80 | 0.13 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 78.41 | 55.42 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.